Provided by Tiger Trade Technology Pte. Ltd.

Allogene Therapeutics Inc.

2.07
-0.1500-6.76%
Post-market: 2.120.0500+2.42%19:35 EDT
Volume:20.75M
Turnover:43.28M
Market Cap:504.62M
PE:-2.39
High:2.26
Open:2.23
Low:2.06
Close:2.22
52wk High:2.80
52wk Low:0.8621
Shares:243.78M
Float Shares:168.00M
Volume Ratio:4.22
T/O Rate:12.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8652
EPS(LYR):-0.8652
ROE:-53.42%
ROA:-26.82%
PB:1.72
PE(LYR):-2.39

Loading ...

Aug 01, 2025

Major Issues Report

Form 8-K - Current report
Jun 23, 2025

Major Issues Report

Form 8-K - Current report
Jun 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Major Issues Report

Form 8-K - Current report
Apr 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 14, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2025

Major Issues Report

Form 8-K - Current report
Feb 25, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Major Issues Report

Form 8-K - Current report
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities